Síndrome linfoproliferativo postrasplante renal con lesión única en sistema nervioso central tratada con radioterapia: reporte de un caso y revisión de la literatura
PDF (Espanhol)

Palavras-chave

trastorno linfoproliferativo postrasplante
radioterapia
trasplante renal
sistema nervioso central

Como Citar

Síndrome linfoproliferativo postrasplante renal con lesión única en sistema nervioso central tratada con radioterapia: reporte de un caso y revisión de la literatura. (2015). Universitas Medica, 56(4), 480-486. https://doi.org/10.11144/Javeriana.umed56-4.slpr
Almetrics
 
Dimensions
 

Google Scholar
 
Search GoogleScholar

Resumo

El síndrome linfoproliferativo postrasplante (SLPT) confinado al sistema nervioso central (SNC) es una entidad extremadamente rara y de mal pronóstico. El tratamiento tiene un impacto significativo en la supervivencia, pues no está claramente estandarizado, dada la poca incidencia de esta entidad y la poca literatura al respecto. La radioterapia es una alternativa de tratamiento en estos pacientes con afectación en el SNC. Se revisaron las principales características de esta patología y se reporta un caso de una adolescente de 13 años de edad con SLPT confinado a SNC como único sitio de compromiso, tratada con radioterapia, en quien se obtuvo una buena respuesta y adecuada tolerancia al tratamiento.

PDF (Espanhol)

Dharnidharka VR, Green M, Weber SA, editores. Posttransplant lymphoproliferative disorders. Berlin: Springer Verlag; 2010.

Jamali FR, Otrock ZK, Soweid AM, Al-awar GN, Mahfouz RA, Haidar GR, Bazarbachi A. An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma. Leuk Lymphoma. 2007 Jun;48(6):1237-41.

Swerdlow SH. T cell and NK-cell post-transplantation lymphoproliferative disorders. Am J Clin Pathol. 2007;127(6):887-95.

Dharnidharka VR. Epidemiology of PTLD. In: Dharnidharka VR, editor. Posttransplant lymphoproliferative disorders. Berlin: Springer Verlag; 2010. p. 17-28.

Taylor AL, Marcus R, Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol. 2005;56(1):155-67.

Cavaliere R, Petroni G, Lopes M et al. Primary central nervous system posttransplantation lymphoproliferative disorder: An International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer. 2010 Jul;15;116(14):3521.

Phan TG, O’Neill BP, Kurtin PJ. Posttransplant primary CNS lymphoma. Neuro Oncology. 2000;2:229-38.

Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation 1995;59(2):240-4.

Morgans A, Reshef R, Tsai DE. Posttransplant lymphoproliferative disorder following kidney transplant. Am J Kidney Dis. 2010 Jan;55(1): 168-80.

This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.

Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.